MSC for the improvement of hematopoietic engraftment

Bone Marrow Transplantation

Volumn 45, Issue 3, 2010, Pages 605-606

  Resnick, I ^a   Stepensky, P ^a   Elkin, G ^a   Barkatz, C ^a   Gurevich, O ^a   Prigozhina, T ^a   Pikarsky, E ^a   Waldman, E ^a   Amar, A ^a   Samuel, S ^a   Shapira, M ^a   Weintraub, M ^a   Or, R ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; THIOTEPA; THYMOCYTE ANTIBODY;

BONE MARROW BIOPSY; CANDIDIASIS; CASE REPORT; CHILD; CHIMERA; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE SEVERITY; ENGRAFTMENT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; WISKOTT ALDRICH SYNDROME;

CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ILIUM; INJECTIONS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; WISKOTT-ALDRICH SYNDROME;

EID: 77949418265     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.199     Document Type: Letter

References (11)

1. Macmillan ML, Blazar BR, Defor TE, Wagner JE. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. Bone Marrow Transplant 2009; 43: 447-454.
2. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring microenvironment of hematopoietic tissues-cloning in vitro and retransplantation in vivo. Transplantation 1974; 17: 331-340.
3. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultureexpanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18: 307-316.
4. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005; 11: 389-398.
5. Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 2007; 110: 2764-2767.
6. Poloni A, Leoni P, Buscemi L, Balducci F, Pasquini R, Masia MC et al. Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen. Leukemia 2006; 20: 329-335.
7. Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, Arvidson J et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 2007; 21: 1733-1738.
8. KoçON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215-222.
9. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002; 99: 8932-8937.
10. Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP. Stem cell transplantation: the lung barrier. Transplant Proc 2007; 39: 573-576.
11. Barkatz C, Mancuta D, Weiss L, Rebstein I, Kurkalli B, Elkin G et al. Mesenchymal stem cells from umbilical cord vein, placenta, and bone marrow demonstrate similar phenotype and immunosuppressive activity which is not mediated by apoptosis. Haematologica 2007; 92(Suppl 1): 404.